Mycoplasma gallisepticum in vivo induced antigens expressed during infection in chickens.

Abstract Until now only a few genes encoding virulence factors have been characterized in the avian pathogen Mycoplasma gallisepticum . In order to identify candidate targets associated with infection we applied an immunoscreening technique— in vivo induced antigen technology (IVIAT)—to detect immunogens of M. gallisepticum strain R low expressed preferentially during in vivo infection. We identified 13 in vivo -induced (IVI) proteins that correspond to different functional categories including: previously reported putative virulence factors (GapA, PlpA, Hlp3, VlhA 1.07 and VlhA 4.01), transport (PotE, MGA_0241 and 0654), translation (L2, L23, ValS), chaperone (GroEL) and a protein with unknown function (MGA_0042). To validate the in vivo antigenic reactivity, 10 IVI proteins were tested by Western blot analysis using serum samples collected from chickens experimentally (with strain R low ) and naturally (outbreaks, N  = 3) infected with M. gallisepticum . All IVI proteins tested were immunogenic. To corroborate these results, we tested expression of IVI genes in chickens experimentally infected with M. gallisepticum R low , and in MRC-5 human lung fibroblasts cell culture by using relative real time reverse-transcription PCR (RT-PCR). With the exception of MGA_0338, all six genes tested (MGA_1199, 0042, 0654, 0712, 0928 and 0241) were upregulated at least at one time point during experimental infection (2–4 week post-infection). In contrast, the expression of seven out of eight IVI genes (MGA_1199, 0152, 0338, 0042, 0654, 0712, 0928) were downregulated in MRC-5 cell culture at both 2 and 4 h PI; MGA_0241 was upregulated 2 h PI. Our data suggest that the identified IVI antigens may have important roles in the pathogenesis of M. gallisepticum infection in vivo .